Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
171,717,172
-
Total 13F shares
-
126,697,163
-
Share change
-
-5,523,095
-
Total reported value
-
$826,050,230
-
Put/Call ratio
-
1059%
-
Price per share
-
$6.52
-
Number of holders
-
171
-
Value change
-
-$42,426,305
-
Number of buys
-
91
-
Number of sells
-
78
Institutional Holders of Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) as of Q2 2024
As of 30 Jun 2024 Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) had 171 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 126,697,163 shares of stock of the company.
Largest 10 holders included SB INVESTMENT ADVISERS (UK) LTD, VANGUARD GROUP INC, BlackRock Inc., Casdin Capital, LLC, Bellevue Group AG, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, JPMORGAN CHASE & CO, Nextech Invest Ltd., and NORGES BANK.
This table shows 171 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.